These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23925288)

  • 81. Octreotide infusion for the treatment of chylothorax in pediatric cardiac intensive care unit.
    Yildirim SV; Kervancioğlu M; Saritaş B; Varan B; Mercan S; Tokel K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):317-8. PubMed ID: 16330401
    [No Abstract]   [Full Text] [Related]  

  • 82. Fetal therapy and cytogenetic testing: prenatal detection of chromosome aberration during thoracocentesis for congenital chylothorax by karyotyping from pleural effusion fluid and review of the literature.
    Chen CP
    Genet Couns; 2005; 16(3):301-5. PubMed ID: 16259328
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Octreotide in the treatment of thoracic duct injuries.
    Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
    Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature.
    Barbetakis N; Xenikakis T; Efstathiou A; Fessatidis I
    Hellenic J Cardiol; 2006; 47(2):118-22. PubMed ID: 16752533
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.
    Sivasli E; Dogru D; Aslan AT; Yurdakok M; Tekinalp G
    J Perinatol; 2004 Apr; 24(4):261-2. PubMed ID: 15067298
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Influence of prolonged treatment with octreotide on GH, IGF I, insulin, ACTH, cortisol, T3, T4 and TSH secretion in a case of congenital chylothorax].
    Bagnoli F; Badii S; Conte ML; Toti MS; De Felice C; Bellieni CV; Borlini G; Tomasini B; Zani S
    Minerva Pediatr; 2010 Aug; 62(4):411-7. PubMed ID: 20940674
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Octreotid as a treatment of congenital chylothorax.
    Bulbul A; Unsur EK
    Pediatr Pulmonol; 2010 Jun; 45(6):628; author reply 629-30. PubMed ID: 20503291
    [No Abstract]   [Full Text] [Related]  

  • 88. [Successful treatment of a case of chylothorax, manifesting as a complication following surgical treatment of coarctation of the aorta, by using octreotide acetate; report of a case].
    Matsushita H; Hanayama N
    Kyobu Geka; 2014 Feb; 67(2):149-52. PubMed ID: 24743487
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Congenital chylothorax: from foetal life to adolescence.
    Caserío S; Gallego C; Martin P; Moral MT; Pallás CR; Galindo A
    Acta Paediatr; 2010 Oct; 99(10):1571-7. PubMed ID: 20528795
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Congenital chylothorax managed by partial pleurodesis: report of one case.
    Chang CA; Teng RJ; Yen SL; Chang S; Ho MM; Hwang KC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(3):211-5. PubMed ID: 8368069
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pleuro-amniotic shunting for fetal chylothorax.
    Booth P; Nicolaides KH; Greenough A; Gamsu HR
    Early Hum Dev; 1987 Nov; 15(6):365-7. PubMed ID: 3436279
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Octreotide in the management of postoperative chylothorax.
    Rosti L; De Battisti F; Butera G; Cirri S; Chessa M; Delogu A; Drago M; Giamberti A; Pomè G; Carminati M; Frigiola A
    Pediatr Cardiol; 2005; 26(4):440-3. PubMed ID: 16374694
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Somatostatin treatment of congenital chylothorax may induce transient hypothyroidism in newborns.
    Maayan-Metzger A; Sack J; Mazkereth R; Vardi A; Kuint J
    Acta Paediatr; 2005 Jun; 94(6):785-9. PubMed ID: 16188789
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Congenital chylothorax in a patient with 21 trisomy syndrome.
    Yamamoto T; Koeda T; Tamura A; Sawada H; Nagata I; Nagata N; Ito T; Mio Y
    Acta Paediatr Jpn; 1996 Dec; 38(6):689-91. PubMed ID: 9002311
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intrapartum drainage of fetal pleural effusion.
    Gonen R; Degani S; Kugelman A; Abend M; Bader D
    Prenat Diagn; 1999 Dec; 19(12):1124-6. PubMed ID: 10590429
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.
    Roehr CC; Jung A; Proquitté H; Blankenstein O; Hammer H; Lakhoo K; Wauer RR
    Intensive Care Med; 2006 May; 32(5):650-7. PubMed ID: 16532329
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.
    Resch B; Sever Yildiz G; Reiterer F
    Respiration; 2022; 101(1):84-96. PubMed ID: 34515211
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Successful prenatal treatment of non-immune hydrops fetalis due to congenital chylothorax. Case report.
    Schmidt W; Harms E; Wolf D
    Br J Obstet Gynaecol; 1985 Jul; 92(7):685-7. PubMed ID: 4016026
    [No Abstract]   [Full Text] [Related]  

  • 99. Octreotide for treatment of postoperative chylothorax.
    Cheung Y; Leung MP; Yip M
    J Pediatr; 2001 Jul; 139(1):157-9. PubMed ID: 11445812
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Congenital neonatal chylothorax with hydrops fetalis treated with octreotide.
    Ibrahim A; Dammas AS
    Sudan J Paediatr; 2013; 13(1):43-8. PubMed ID: 27493357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.